{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:31:09Z","timestamp":1789065069870,"version":"build-2803163510"},"reference-count":61,"publisher":"Impact Journals, LLC","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2024,7,15]]},"DOI":"10.18632\/aging.205994","type":"journal-article","created":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T16:50:03Z","timestamp":1719679803000},"page":"10694-10723","source":"Crossref","is-referenced-by-count":12,"title":["Modulating in vitro lung fibroblast activation via senolysis of senescent human alveolar epithelial cells"],"prefix":"10.18632","volume":"16","author":[{"given":"Joseph S.","family":"Spina","sequence":"first","affiliation":[{"name":"AbbVie Bioresearch Center, Worcester, MA 01605, USA"},{"name":"Department of Biology, Northeastern University, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy L.","family":"Carr","sequence":"additional","affiliation":[{"name":"AbbVie Inc., North Chicago, IL 60064, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy A.","family":"Phillips","sequence":"additional","affiliation":[{"name":"AbbVie Bioresearch Center, Worcester, MA 01605, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Knight","sequence":"additional","affiliation":[{"name":"AbbVie Bioresearch Center, Worcester, MA 01605, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E.","family":"Crosbie","sequence":"additional","affiliation":[{"name":"AbbVie Bioresearch Center, Worcester, MA 01605, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Lloyd","sequence":"additional","affiliation":[{"name":"AbbVie Inc., North Chicago, IL 60064, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha A.","family":"Jhala","sequence":"additional","affiliation":[{"name":"AbbVie Inc., North Chicago, IL 60064, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony J.","family":"Lam","sequence":"additional","affiliation":[{"name":"AbbVie Inc., North Chicago, IL 60064, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozsef","family":"Karman","sequence":"additional","affiliation":[{"name":"AbbVie Bioresearch Center, Worcester, MA 01605, USA"},{"name":"Current address: Merck, Cambridge, MA 02141, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan E.","family":"Clements","sequence":"additional","affiliation":[{"name":"AbbVie Bioresearch Center, Worcester, MA 01605, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tovah A.","family":"Day","sequence":"additional","affiliation":[{"name":"Department of Biology, Northeastern University, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin D.","family":"Crane","sequence":"additional","affiliation":[{"name":"Department of Biology, Northeastern University, Boston, MA 02115, USA"},{"name":"Current address: Pfizer Inc., Cambridge, MA 02139, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Housley","sequence":"additional","affiliation":[{"name":"AbbVie Bioresearch Center, Worcester, MA 01605, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2024,6,29]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline.","volume":"20","author":"Nicholson","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/S2213-2600(20)30318-0","article-title":"Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.","volume":"8","author":"Wagner","year":"2020","journal-title":"Lancet Respir Med"},{"key":"3","doi-asserted-by":"publisher","first-page":"17074","DOI":"10.1038\/nrdp.2017.74","article-title":"Idiopathic pulmonary fibrosis.","volume":"3","author":"Wells","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"4","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1016\/j.ajpath.2016.07.004","article-title":"Lung Pericytes and Resident Fibroblasts: Busy Multitaskers.","volume":"18","author":"Duffield","year":"2016","journal-title":"Am J Pathol"},{"key":"5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41556-021-00809-4","article-title":"Human alveolar type 2 epithelium transdifferentiates into metaplastic KRT5basal cells.","volume":"2","author":"Peng","year":"2022","journal-title":"Nat Cell Biol"},{"key":"6","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1038\/s41467-020-17358-3","article-title":"Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis.","volume":"1","author":"Kukhtevich","year":"2020","journal-title":"Nat Commun"},{"key":"7","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s41556-020-0542-8","article-title":"Persistence of a regeneration-associated, transitional alveolar epithelial cell state in pulmonary fibrosis.","volume":"2","author":"Tata","year":"2020","journal-title":"Nat Cell Biol"},{"key":"8","doi-asserted-by":"publisher","first-page":"143626","DOI":"10.1172\/jci.insight.143626","article-title":"Molecular mapping of interstitial lung disease reveals a phenotypically distinct senescent basal epithelial cell population.","volume":"6","author":"Arron","year":"2021","journal-title":"JCI Insight"},{"key":"9","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.stem.2020.06.020","article-title":"Inflammatory Signals Induce AT2 Cell-Derived Damage-Associated Transient Progenitors that Mediate Alveolar Regeneration.","volume":"2","author":"Lee","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3390\/cells11050877","article-title":"Molecular Mechanisms of Alveolar Epithelial Stem Cell Senescence and Senescence-Associated Differentiation Disorders in Pulmonary Fibrosis.","volume":"1","author":"Liu","year":"2022","journal-title":"Cells"},{"key":"11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/0014-4827(61)90192-6","article-title":"The serial cultivation of human diploid cell strains.","volume":"2","author":"Moorhead","year":"1961","journal-title":"Exp Cell Res"},{"key":"12","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3390\/pharmaceutics12040389","article-title":"Senescence of IPF Lung Fibroblasts Disrupt Alveolar Epithelial Cell Proliferation and Promote Migration in Wound Healing.","volume":"1","author":"Knight","year":"2020","journal-title":"Pharmaceutics"},{"key":"13","doi-asserted-by":"publisher","first-page":"130056","DOI":"10.1172\/jci.insight.130056","article-title":"Secretion of leukotrienes by senescent lung fibroblasts promotes pulmonary fibrosis.","volume":"4","author":"Jourdan Le Saux","year":"2019","journal-title":"JCI Insight"},{"key":"14","doi-asserted-by":"publisher","first-page":"e12858","DOI":"10.1111\/acel.12858","article-title":"Loss of PTEN induces lung fibrosis via alveolar epithelial cell senescence depending on NF-\u03baB activation.","volume":"1","author":"Cai","year":"2019","journal-title":"Aging Cell"},{"key":"15","doi-asserted-by":"publisher","first-page":"14532","DOI":"10.1038\/ncomms14532","article-title":"Cellular senescence mediates fibrotic pulmonary disease.","volume":"8","author":"Fuhrmann-Stroissnigg","year":"2017","journal-title":"Nat Commun"},{"key":"16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ijrobp.2017.02.216","article-title":"Inhibition of Bcl-2\/xl With ABT-263 Selectively Kills Senescent Type II Pneumocytes and Reverses Persistent Pulmonary Fibrosis Induced by Ionizing Radiation in Mice.","volume":"9","author":"Meng","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"17","doi-asserted-by":"publisher","first-page":"1602367","DOI":"10.1183\/13993003.02367-2016","article-title":"Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo.","volume":"5","author":"K\u00f6nigshoff","year":"2017","journal-title":"Eur Respir J"},{"key":"18","doi-asserted-by":"publisher","first-page":"e1481","DOI":"10.1210\/clinem\/dgaa728","article-title":"New Horizons: Novel Approaches to Enhance Healthspan Through Targeting Cellular Senescence and Related Aging Mechanisms.","volume":"10","author":"Kirkland","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"19","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/s41591-018-0092-9","article-title":"Senolytics improve physical function and increase lifespan in old age.","volume":"2","author":"Verzosa","year":"2018","journal-title":"Nat Med"},{"key":"20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","article-title":"The senescence-associated secretory phenotype: the dark side of tumor suppression.","volume":"5","author":"Campisi","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"21","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1164\/rccm.202004-1274OC","article-title":"Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis.","volume":"20","author":"Jiang","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"22","doi-asserted-by":"publisher","first-page":"328","DOI":"10.18632\/aging.100897","article-title":"NKG2D ligands mediate immunosurveillance of senescent cells.","volume":"8","author":"Krizhanovsky","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"23","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ebiom.2018.12.052","article-title":"Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study.","volume":"4","author":"Kirkland","year":"2019","journal-title":"EBioMedicine"},{"key":"24","doi-asserted-by":"publisher","first-page":"e163762","DOI":"10.1172\/jci.insight.163762","article-title":"Inhibition of antiapoptotic BCL-2 proteins with ABT-263 induces fibroblast apoptosis, reversing persistent pulmonary fibrosis.","volume":"8","author":"Redente","year":"2023","journal-title":"JCI Insight"},{"key":"25","doi-asserted-by":"publisher","first-page":"eaal3765","DOI":"10.1126\/scitranslmed.aal3765","article-title":"Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis.","volume":"9","author":"Baron","year":"2017","journal-title":"Sci Transl Med"},{"key":"26","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.7150\/jca.15566","article-title":"Bleomycin (BLM) Induces Epithelial-to-Mesenchymal Transition in Cultured A549 Cells via the TGF-\u03b2\/Smad Signaling Pathway.","volume":"7","author":"Wang","year":"2016","journal-title":"J Cancer"},{"key":"27","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1183\/09031936.03.00011903","article-title":"Bleomycin induces cellular senescence in alveolar epithelial cells.","volume":"2","author":"Nagai","year":"2003","journal-title":"Eur Respir J"},{"key":"28","doi-asserted-by":"publisher","first-page":"242","DOI":"10.18632\/aging.102613","article-title":"Epithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation.","volume":"1","author":"Dai","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"29","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/febs.16350","article-title":"Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.","volume":"29","author":"Robbins","year":"2023","journal-title":"FEBS J"},{"key":"30","doi-asserted-by":"publisher","first-page":"E6301","DOI":"10.1073\/pnas.1515386112","article-title":"JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age.","volume":"11","author":"Kirkland","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"31","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s10637-021-01066-w","article-title":"AD80, a multikinase inhibitor, exhibits antineoplastic effects in acute leukemia cellular models targeting the PI3K\/STMN1 axis.","volume":"3","author":"Machado-Neto","year":"2021","journal-title":"Invest New Drugs"},{"key":"32","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.3390\/cancers15153866","article-title":"The Multikinase Inhibitor AD80 Induces Mitotic Catastrophe and Autophagy in Pancreatic Cancer Cells.","volume":"1","author":"Machado-Neto","year":"2023","journal-title":"Cancers (Basel)"},{"key":"33","doi-asserted-by":"publisher","first-page":"588543","DOI":"10.3389\/fimmu.2020.588543","article-title":"The JAK1 Selective Inhibitor ABT 317 Blocks Signaling Through Interferon-\u03b3 and Common \u03b3 Chain Cytokine Receptors to Reverse Autoimmune Diabetes in NOD Mice.","volume":"1","author":"Thomas","year":"2020","journal-title":"Front Immunol"},{"key":"34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.mrfmmm.2004.08.021","article-title":"INK4a\/ARF: a multifunctional tumor suppressor locus.","volume":"57","author":"Sharpless","year":"2005","journal-title":"Mutat Res"},{"key":"35","doi-asserted-by":"publisher","first-page":"1059434","DOI":"10.3389\/fphar.2022.1059434","article-title":"Senescent AECII and the implication for idiopathic pulmonary fibrosis treatment.","volume":"1","author":"Song","year":"2022","journal-title":"Front Pharmacol"},{"key":"36","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1183\/09031936.00146413","article-title":"Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities.","volume":"4","author":"Giangreco","year":"2014","journal-title":"Eur Respir J"},{"key":"37","doi-asserted-by":"publisher","first-page":"e153058","DOI":"10.1172\/jci.insight.153058","article-title":"Increased expression and accumulation of GDF15 in IPF extracellular matrix contribute to fibrosis.","volume":"7","author":"Murray","year":"2022","journal-title":"JCI Insight"},{"key":"38","doi-asserted-by":"publisher","first-page":"e14012","DOI":"10.1111\/acel.14012","article-title":"Form follows function: Nuclear morphology as a quantifiable predictor of cellular senescence.","volume":"2","author":"Lomakin","year":"2023","journal-title":"Aging Cell"},{"key":"39","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1038\/s41467-020-15647-5","article-title":"Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis.","volume":"1","author":"Sheppard","year":"2020","journal-title":"Nat Commun"},{"key":"40","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/S1470-2045(10)70261-8","article-title":"Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity.","volume":"1","author":"Elmore","year":"2010","journal-title":"Lancet Oncol"},{"key":"41","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s40262-019-00766-0","article-title":"Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib.","volume":"5","author":"Dallinger","year":"2019","journal-title":"Clin Pharmacokinet"},{"key":"42","doi-asserted-by":"publisher","first-page":"L1164","DOI":"10.1152\/ajplung.00220.2017","article-title":"IPF lung fibroblasts have a senescent phenotype.","volume":"31","author":"Shiva","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.matbio.2017.10.004","article-title":"Extracellular matrix alterations in senescent cells and their significance in tissue homeostasis.","volume":"75","author":"Kletsas","year":"2019","journal-title":"Matrix Biol"},{"key":"44","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1371\/journal.pmed.0050093","article-title":"MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis.","volume":"5","author":"Selman","year":"2008","journal-title":"PLoS Med"},{"key":"45","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1513\/pats.200601-012TK","article-title":"Matrix metalloproteases in aberrant fibrotic tissue remodeling.","volume":"3","author":"Selman","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"46","doi-asserted-by":"publisher","first-page":"25964","DOI":"10.1074\/jbc.M113.459784","article-title":"Matrix metalloproteinase (MMP)-1 induces lung alveolar epithelial cell migration and proliferation, protects from apoptosis, and represses mitochondrial oxygen consumption.","volume":"28","author":"Pardo","year":"2013","journal-title":"J Biol Chem"},{"key":"47","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.ajpath.2011.06.041","article-title":"Matrix metalloproteinase 3 is a mediator of pulmonary fibrosis.","volume":"17","author":"Kaminski","year":"2011","journal-title":"Am J Pathol"},{"key":"48","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.tips.2021.01.007","article-title":"Therapeutic Targeting of IL-11 for Chronic Lung Disease.","volume":"4","author":"Gosens","year":"2021","journal-title":"Trends Pharmacol Sci"},{"key":"49","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3390\/biomedicines9091162","article-title":"A Senescence Bystander Effect in Human Lung Fibroblasts.","volume":"9","author":"Knight","year":"2021","journal-title":"Biomedicines"},{"key":"50","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12931-022-02067-w","article-title":"Digital quantification of p16-positive foci in fibrotic interstitial lung disease is associated with a phenotype of idiopathic pulmonary fibrosis with reduced survival.","volume":"2","author":"Mura","year":"2022","journal-title":"Respir Res"},{"key":"51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12931-023-02333-5","article-title":"Epithelial senescence in idiopathic pulmonary fibrosis is propagated by small extracellular vesicles.","volume":"2","author":"Molyneaux","year":"2023","journal-title":"Respir Res"},{"key":"52","doi-asserted-by":"publisher","first-page":"999600","DOI":"10.3389\/fcell.2022.999600","article-title":"Alveolar type 2 epithelial cell senescence and radiation-induced pulmonary fibrosis.","volume":"1","author":"Gu","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"53","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.3390\/ijms21072269","article-title":"Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis.","volume":"2","author":"Chen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"54","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/s41591-022-01923-y","article-title":"Cellular senescence and senolytics: the path to the clinic.","volume":"2","author":"Kirkland","year":"2022","journal-title":"Nat Med"},{"key":"55","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1038\/s41598-023-30844-0","article-title":"Standard of care drugs do not modulate activity of senescent primary human lung fibroblasts.","volume":"1","author":"Hogaboam","year":"2023","journal-title":"Sci Rep"},{"key":"56","doi-asserted-by":"publisher","first-page":"e000397","DOI":"10.1136\/bmjresp-2018-000397","article-title":"Safety and survival data in patients with idiopathic pulmonary fibrosis treated with nintedanib: pooled data from six clinical trials.","volume":"6","author":"Richeldi","year":"2019","journal-title":"BMJ Open Respir Res"},{"key":"57","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1158\/1535-7163.MCT-18-0571","article-title":"Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC Polypharmacology.","volume":"1","author":"Dar","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"58","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/emboj.2011.69","article-title":"p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype.","volume":"3","author":"Campisi","year":"2011","journal-title":"EMBO J"},{"key":"59","doi-asserted-by":"publisher","first-page":"991","DOI":"10.2147\/DDDT.S353494","article-title":"Therapeutic Potential of Janus Kinase Inhibitors for the Management of Interstitial Lung Disease.","volume":"1","author":"Xu","year":"2022","journal-title":"Drug Des Devel Ther"},{"key":"60","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.phrs.2016.05.015","article-title":"Perspective: Targeting the JAK\/STAT pathway to fight age-related dysfunction.","volume":"11","author":"Kirkland","year":"2016","journal-title":"Pharmacol Res"},{"key":"61","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s42490-019-0014-z","article-title":"A high content, phenotypic 'scar-in-a-jar' assay for rapid quantification of collagen fibrillogenesis using disease-derived pulmonary fibroblasts.","volume":"1","author":"Nanthakumar","year":"2019","journal-title":"BMC Biomed Eng"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205994","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T14:31:01Z","timestamp":1721917861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,29]]},"references-count":61,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2024,7,15]]}},"alternative-id":["205994","38976646"],"URL":"https:\/\/doi.org\/10.18632\/aging.205994","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,29]]}}}